NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Market Cap: 128.53M for April 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 05, 2024 | 128.53M |
| April 04, 2024 | 128.53M |
| April 03, 2024 | 130.20M |
| April 02, 2024 | 130.20M |
| April 01, 2024 | 130.20M |
| March 28, 2024 | 132.71M |
| March 27, 2024 | 135.21M |
| March 26, 2024 | 129.37M |
| March 25, 2024 | 129.37M |
| March 22, 2024 | 129.37M |
| March 21, 2024 | 130.20M |
| March 20, 2024 | 129.37M |
| March 19, 2024 | 130.20M |
| March 18, 2024 | 130.20M |
| March 15, 2024 | 131.04M |
| March 14, 2024 | 127.70M |
| March 13, 2024 | 127.70M |
| March 12, 2024 | 128.53M |
| March 11, 2024 | 128.53M |
| March 08, 2024 | 127.70M |
| March 07, 2024 | 127.70M |
| March 06, 2024 | 126.86M |
| March 05, 2024 | 127.70M |
| March 04, 2024 | 126.86M |
| March 01, 2024 | 126.86M |
| Date | Value |
|---|---|
| February 29, 2024 | 126.86M |
| February 28, 2024 | 127.70M |
| February 27, 2024 | 136.04M |
| February 26, 2024 | 127.28M |
| February 23, 2024 | 159.41M |
| February 22, 2024 | 159.41M |
| February 21, 2024 | 159.18M |
| February 20, 2024 | 133.48M |
| February 16, 2024 | 126.85M |
| February 15, 2024 | 123.53M |
| February 14, 2024 | 121.87M |
| February 13, 2024 | 121.87M |
| February 12, 2024 | 126.02M |
| February 09, 2024 | 126.02M |
| February 08, 2024 | 118.56M |
| February 07, 2024 | 118.56M |
| February 06, 2024 | 117.73M |
| February 05, 2024 | 115.24M |
| February 02, 2024 | 119.39M |
| February 01, 2024 | 123.53M |
| January 31, 2024 | 126.85M |
| January 30, 2024 | 128.51M |
| January 29, 2024 | 127.68M |
| January 26, 2024 | 123.53M |
| January 25, 2024 | 116.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
49.65M
Minimum
Nov 17 2023
2.449B
Maximum
Mar 17 2021
1.015B
Average
1.153B
Median
Jan 25 2022
Market Cap Benchmarks
| Catalent Inc | 10.95B |
| AIM ImmunoTech Inc | 16.00M |
| Perspective Therapeutics Inc | 847.57M |
| Protalix BioTherapeutics Inc | 77.22M |
| Armata Pharmaceuticals Inc | 85.39M |
Market Cap Related Metrics
| PS Ratio | 28.76 |
| Price to Book Value | 0.8647 |
| Price | 1.54 |
| Earnings Yield | -112.3% |